France M, Del Rio T, Travers H, Raftery E, Xu K, Langer R, et al. Ultra-rapid drug delivery in the oral cavity using ultrasound. J Control Release. 2019;304:1-6 pubmed publisher

Galbraith A, Seabloom D, Wuertz B, Antonides J, Steele V, Wattenberg L, et al. Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide. Cancer Prev Res (Phila). 2019;12:69-78 pubmed publisher

Date A, Halpert G, Babu T, Ortiz J, Kanvinde P, Dimitrion P, et al. Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease. Biomaterials. 2018;185:97-105 pubmed publisher

Trybus E, Krol G, Obarzanowski T, Trybus W, Kopacz Bednarska A, Obarzanowski M, et al. In vivo and in vitro studies on multidirectional mechanism of anti-allergic activity of budesonide. J Physiol Pharmacol. 2017;68:907-919 pubmed

Vissiennon C, Hammoud D, Rodewald S, Fester K, Goos K, Nieber K, et al. Chamomile Flower, Myrrh, and Coffee Charcoal, Components of a Traditional Herbal Medicinal Product, Diminish Proinflammatory Activation in Human Macrophages. Planta Med. 2017;83:846-854 pubmed publisher

Wagner C, Goldmann T, Rohmann K, Rupp J, Marwitz S, Rotta Detto Loria J, et al. Budesonide Inhibits Intracellular Infection with Non-Typeable Haemophilus influenzae Despite Its Anti-Inflammatory Effects in Respiratory Cells and Human Lung Tissue: A Role for p38 MAP Kinase. Respiration. 2015;90:416-25 pubmed publisher

Dufour G, Bigazzi W, Wong N, Boschini F, de Tullio P, Piel G, et al. Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide. Int J Pharm. 2015;495:869-78 pubmed publisher

Teixeira Castro A, Jalles A, Esteves S, Kang S, da Silva Santos L, Silva Fernandes A, et al. Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease. Brain. 2015;138:3221-37 pubmed publisher

Dauletbaev N, Cammisano M, Herscovitch K, Lands L. Stimulation of the RIG-I/MAVS Pathway by Polyinosinic:Polycytidylic Acid Upregulates IFN-β in Airway Epithelial Cells with Minimal Costimulation of IL-8. J Immunol. 2015;195:2829-41 pubmed publisher

Meindl C, Stranzinger S, Dzidic N, Salar Behzadi S, Mohr S, Zimmer A, et al. Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro. PLoS ONE. 2015;10:e0135690 pubmed publisher

Gao K, Yu P, Su J, He C, Liu L, Zhou Y, et al. Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery: A study for 342 cases. Thorac Cancer. 2015;6:443-9 pubmed publisher

Naeem M, Choi M, Cao J, Lee Y, Ikram M, Yoon S, et al. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy. Drug Des Devel Ther. 2015;9:3789-99 pubmed publisher

Ufuk A, Somers G, Houston J, Galetin A. In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383. Pharm Res. 2015;32:3937-51 pubmed publisher

Naeem M, Cao J, Choi M, Kim W, Moon H, Lee B, et al. Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles. Int J Nanomedicine. 2015;10:4565-80 pubmed publisher

Sun J, Zhang P, Zhang B, Li K, Li Z, Li J, et al. Budesonide ameliorates lung function of the cigarette smoke-exposed rats through reducing matrix metalloproteinase-1 content. Int J Clin Exp Pathol. 2015;8:5137-44 pubmed

Lin H, Chung C, Lin Y, Yu C, Lee C, Bien M. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach. PLoS ONE. 2015;10:e0130102 pubmed publisher

Wang L, Zhang B, Li Z, Li J, Liu Q, Sun W. Budesonide mitigates pathological changes in animal model Of COPD through reducing neutrophil elastase expression. Int J Clin Exp Med. 2015;8:5227-35 pubmed

Devillier P, Garrigue E, D Auzers G, Monjotin N, Similowski T, Clerc T. V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results. Respir Res. 2015;16:68 pubmed publisher

Chrystyn H, Safioti G, Keegstra J, Gopalan G. Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler. Int J Pharm. 2015;491:268-76 pubmed publisher

Liang Y, Liu G, Zheng H, Li Y, Chen L, Fu Y, et al. Management of Benign Tracheal Stenosis by Small-diameter Tube-assisted Bronchoscopic Balloon Dilatation. Chin Med J (Engl). 2015;128:1326-30 pubmed publisher

Gao W, Ju N. Budesonide inhalation ameliorates endotoxin-induced lung injury in rabbits. Exp Biol Med (Maywood). 2015;240:1708-16 pubmed publisher

Verheijden K, Willemsen L, Braber S, Leusink Muis T, Delsing D, Garssen J, et al. Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model. Respir Res. 2015;16:17 pubmed publisher

Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, et al. Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2015;191:1242-9 pubmed publisher

Karsli Ceppioğlu S, Ngollo M, Adjakly M, Dagdemir A, Judes G, Lebert A, et al. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?. OMICS. 2015;19:209-19 pubmed publisher

Lähelmä S, Sairanen U, Haikarainen J, Korhonen J, Vahteristo M, Fuhr R, et al. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler. J Aerosol Med Pulm Drug Deliv. 2015;28:462-73 pubmed publisher

Israel E, Roche N, Martin R, Colice G, Dorinsky P, Postma D, et al. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma. Ann Am Thorac Soc. 2015;12:798-806 pubmed publisher

Rodríguez Martínez C, Sossa Briceño M, Vladimir Lemos E. Cost-effectiveness analysis of mometasone furoate versus beclomethasone dipropionate for the treatment of pediatric allergic rhinitis in Colombia. Adv Ther. 2015;32:254-69 pubmed publisher

Castanhinha S, Sherburn R, Walker S, Gupta A, Bossley C, Buckley J, et al. Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol. 2015;136:312-22.e7 pubmed publisher

Fingleton J, Travers J, Williams M, Charles T, Bowles D, Strik R, et al. Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. J Allergy Clin Immunol. 2015;136:601-9 pubmed publisher

Sutovska M, Kocmálová M, Jošková M, Adamkov M, Franova S. The effect of long-term administered CRAC channels blocker on the functions of respiratory epithelium in guinea pig allergic asthma model. Gen Physiol Biophys. 2015;34:167-76 pubmed publisher

Chandel S, Prakash A, Medhi B. Current scenario in inflammatory bowel disease: drug development prospects. Pharmacol Rep. 2015;67:224-9 pubmed publisher

Sadatsafavi M, Lynd L, De Vera M, Zafari Z, FitzGerald J. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge. Respir Med. 2015;109:320-8 pubmed publisher

Sandborn W, Danese S, D Haens G, Moro L, Jones R, Bagin R, et al. Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. Aliment Pharmacol Ther. 2015;41:409-18 pubmed publisher

Lai T, Chen M, Deng Z, L Y, Wu D, Li D, et al. YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment. BMC Pulm Med. 2015;15:1 pubmed publisher

Mello C, Ramos L, Gimenes A, Andrade T, Oliani S, Gil C. Immunomodulatory effects of galectin-1 on an IgE-mediated allergic conjunctivitis model. Invest Ophthalmol Vis Sci. 2015;56:693-704 pubmed publisher

Ziffels S, Bemelmans N, Durham P, Hickey A. In vitro dry powder inhaler formulation performance considerations. J Control Release. 2015;199:45-52 pubmed publisher

Gauvreau G, Boulet L, Leigh R, Cockcroft D, Killian K, Davis B, et al. A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses. Am J Respir Crit Care Med. 2015;191:161-7 pubmed publisher

Zhang F, Ngoc N, Tay B, Mendyk A, Shao Y, Lau R. Roughness-controlled self-assembly of mannitol/LB agar microparticles by polymorphic transformation for pulmonary drug delivery. Mol Pharm. 2015;12:223-31 pubmed publisher

Ramachandran V, Murnane D, Hammond R, Pickering J, Roberts K, Soufian M, et al. Formulation pre-screening of inhalation powders using computational atom-atom systematic search method. Mol Pharm. 2015;12:18-33 pubmed publisher

Flinders B, Morrell J, Marshall P, Ranshaw L, Clench M. The use of hydrazine-based derivatization reagents for improved sensitivity and detection of carbonyl containing compounds using MALDI-MSI. Anal Bioanal Chem. 2015;407:2085-94 pubmed publisher

Danhaive O, Chapin C, Horneman H, Cogo P, Ballard P. Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B. Pediatr Res. 2015;77:340-6 pubmed publisher

Finkin Groner E, Moradov D, Shifrin H, Bejar C, Nudelman A, Weinstock M. Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS. Br J Pharmacol. 2015;172:1101-13 pubmed publisher

Kazimierová I, Jošková M, Pecháňová O, Šutovská M, Fraňová S. Effects of provinol and its combinations with clinically used antiasthmatics on airway defense mechanisms in experimental allergic asthma. Adv Exp Med Biol. 2015;838:27-34 pubmed publisher

Zhang W, Zhi J, Cui Y, Zhang F, Habyarimana A, Cambier C, et al. Potentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in rats. PLoS ONE. 2014;9:e109136 pubmed publisher

Mascaraque C, Aranda C, Ocón B, Monte M, Suárez M, Zarzuelo A, et al. Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis. Pharmacol Res. 2014;90:48-57 pubmed publisher

Hira D, Koshiyama S, Komase Y, Hoshino N, Morita S, Terada T. Dry mouth as a novel indicator of hoarseness caused by inhalation therapy. J Asthma. 2015;52:296-300 pubmed publisher

Wielgat P, Mroz R, Stasiak Barmuta A, Szepiel P, Chyczewska E, Braszko J, et al. Inhaled corticosteroids increase siglec-5/14 expression in sputum cells of COPD patients. Adv Exp Med Biol. 2015;839:1-5 pubmed publisher

Hua Y, Shun T, Strock C, Johnston P. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions. Assay Drug Dev Technol. 2014;12:395-418 pubmed publisher

Alexandrou A, Armeni E, Kaparos G, Rizos D, Tsoka E, Deligeoroglou E, et al. Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery. J Invest Surg. 2015;28:8-17 pubmed publisher

Drug V, Antoniu S. Efficacy of budesonide in collagenous colitis Evaluation of: Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146(5):1222-1230 e12. Expert Opin Pharmacother. 2014;15:2277-9 pubmed publisher

Kuenzig M, Rezaie A, Seow C, Otley A, Steinhart A, Griffiths A, et al. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2014;:CD002913 pubmed publisher

Grekas N, Athanassiou K, Papataxiarchou K, Rizea Savu S, Silvestro L. Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol. J Pharm Pharmacol. 2014;66:1677-85 pubmed publisher

Schmiedl A, Grützner D, Hoffmann T, von Horsten S, Stephan M. DPP4 inhibitors increase differentially the expression of surfactant proteins in Fischer 344 rats. Acta Physiol (Oxf). 2014;212:248-61 pubmed publisher

Luo X, Ma R, Wu X, Xian D, Li J, Mou Z, et al. Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis. Eur Arch Otorhinolaryngol. 2015;272:1165-73 pubmed publisher

Xia M, Ding X, Qi J, Gu J, Hu G, Sun X. Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain. J Neuroimmunol. 2014;273:53-7 pubmed publisher

Luo S, Pauluhn J, Trübel H, Wang C. Corticosteroids found ineffective for phosgene-induced acute lung injury in rats. Toxicol Lett. 2014;229:85-92 pubmed publisher

Petsky H, Li A, Au C, Kynaston J, Turner C, Chang A. Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: A dual centre randomized controlled trial. Pediatr Pulmonol. 2015;50:535-43 pubmed publisher

Ishiguro H, Kawahara T, Zheng Y, Kashiwagi E, Li Y, Miyamoto H. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. Cancer Chemother Pharmacol. 2014;74:249-55 pubmed publisher

May S, Jensen B, Weiler C, Wolkenhauer M, Schneider M, Lehr C. Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles. Pharm Res. 2014;31:3211-24 pubmed publisher

Sagar S, Morgan M, Chen S, Vos A, Garssen J, van Bergenhenegouwen J, et al. Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma. Respir Res. 2014;15:46 pubmed publisher

Parrish D, Sharma S, Kumar S. Is the consistency more important than the ingredients for steroid treatment in eosinophilic esophagitis?. Ann Allergy Asthma Immunol. 2014;112:286-9 pubmed publisher

Tashkin D, Chipps B, Trudo F, Zangrilli J. Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses. J Asthma. 2014;51:603-9 pubmed publisher

Hongjia L, Caiqing Z, Degan L, Fen L, Chao W, Jinxiang W, et al. IL-25 promotes Th2 immunity responses in airway inflammation of asthmatic mice via activation of dendritic cells. Inflammation. 2014;37:1070-7 pubmed publisher

Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks H, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology. 2014;146:1222-30.e1-2 pubmed publisher

Alangari A, Malhis N, Mubasher M, Al Ghamedi N, Al Tannir M, Riaz M, et al. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children: a double-blind, randomized, controlled trial. Chest. 2014;145:772-778 pubmed publisher

Beasley R, Weatherall M, Shirtcliffe P, Hancox R, Reddel H. Combination corticosteroid/?-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?. J Allergy Clin Immunol. 2014;133:39-41 pubmed publisher

Kew K, Karner C, Mindus S, Ferrara G. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;:CD009019 pubmed publisher

Fiocchi A, Dahdah L, Martelli A, Mazzina O, Manzotti G. Spice allergies in children. Ann Allergy Asthma Immunol. 2014;112:72-3 pubmed publisher

van de Griendt E, Verkleij M, Douwes J, van Aalderen W, Geenen R. Problematic severe asthma in children treated at high altitude: tapering the dose while improving control. J Asthma. 2014;51:315-9 pubmed publisher

Chana K, Fenwick P, Nicholson A, Barnes P, Donnelly L. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2014;133:207-16.e1-11 pubmed publisher

Nyström M, Murtomaa M, Roine J, Sandler N, Salonen J. Processing of pharmaceutical materials by electrospraying under reduced pressure. Drug Dev Ind Pharm. 2015;41:116-23 pubmed publisher

Ju N, Gao H, Huang W, Niu F, Lan W, Li F, et al. Therapeutic effect of inhaled budesonide (Pulmicort® Turbuhaler) on the inflammatory response to one-lung ventilation. Anaesthesia. 2014;69:14-23 pubmed publisher

Nissly T, Prasad S. This asthma treatment has a lasting side effect in children. J Fam Pract. 2013;62:500-2 pubmed

Roth F, Quintar A, Leimgruber C, Garcia L, Uribe Echevarría E, Torres A, et al. Restoration of the normal Clara cell phenotype after chronic allergic inflammation. Int J Exp Pathol. 2013;94:399-411 pubmed publisher

Mieli Vergani G, Vergani D. Budesonide for juvenile autoimmune hepatitis? Not yet. J Pediatr. 2013;163:1246-8 pubmed publisher

Shur J, Pitchayajittipong C, Rogueda P, Price R. Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers. Ther Deliv. 2013;4:925-37 pubmed publisher

Perkins M, Wong B, Rodriguez A, Devorak J, Alves D, Murphy G, et al. Inhalation toxicity of soman vapor in non-anesthetized rats: a preliminary assessment of inhaled bronchodilator or steroid therapy. Chem Biol Interact. 2013;206:452-61 pubmed publisher

Woynarowski M, Nemeth A, Baruch Y, Koletzko S, Melter M, Rodeck B, et al. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr. 2013;163:1347-53.e1 pubmed publisher

Mane S, Jordan P, Bahna S. Eosinophilic esophagitis to unsuspected rare food allergen. Ann Allergy Asthma Immunol. 2013;111:64-5 pubmed publisher

Chen J, Mo Y, Schlueter C, Hoyle G. Inhibition of chlorine-induced pulmonary inflammation and edema by mometasone and budesonide. Toxicol Appl Pharmacol. 2013;272:408-13 pubmed publisher

Kupczyk M, Dahlen S. The number needed to treat provides additional insight on the performance of detection points of asthma exacerbations in self-management plans: authors' response on behalf of the BIOAIR consortium. Thorax. 2013;68:1070 pubmed publisher

Saglani S, Lui S, Ullmann N, Campbell G, Sherburn R, Mathie S, et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol. 2013;132:676-685.e13 pubmed publisher

Margagnoni G, Clemente V, Aratari A, Fasci Spurio F, De Gregorio A, Spagnolo A, et al. [Prevention of post-operative recurrence in Crohn's disease: a critical review of randomized controlled trials and meta-analyses of different therapeutic strategies]. Recenti Prog Med. 2013;104:168-76 pubmed publisher

Panina N, Il kovich M. [Easyhalers in practice for treating patients with asthma]. Ter Arkh. 2013;85:98-101 pubmed

Janson C, Larsson K, Lisspers K, Stallberg B, Stratelis G, Goike H, et al. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting ?2 agonist: observational matched cohort study (PATHOS). BMJ. 2013;346:f3306 pubmed publisher

Beloqui A, Coco R, Alhouayek M, Solinís M, Rodríguez Gascón A, Muccioli G, et al. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. Int J Pharm. 2013;454:775-83 pubmed publisher

Tse S, Gold D, Sordillo J, Hoffman E, Gillman M, Rifas Shiman S, et al. Diagnostic accuracy of the bronchodilator response in children. J Allergy Clin Immunol. 2013;132:554-559.e5 pubmed publisher

Xu Q, Zhang N, Qin W, Liu J, Jia Z, Liu H. Preparation, in vitro and in vivo evaluation of budesonide loaded core/shell nanofibers as oral colonic drug delivery system. J Nanosci Nanotechnol. 2013;13:149-56 pubmed

Guo R, Sun P, Zhao A, Gu J, Ding X, Qi J, et al. Chronic asthma results in cognitive dysfunction in immature mice. Exp Neurol. 2013;247:209-17 pubmed publisher

Obase Y, Ikeda M, Kurose K, Abe M, Shimizu H, Ohue Y, et al. Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect. J Asthma. 2013;50:718-21 pubmed publisher

Cates C, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;:CD007313 pubmed publisher

Atreya R, Neumann H, Neurath M. [Rational treatment of Crohn's disease]. MMW Fortschr Med. 2013;155:61-3 pubmed

Kupczyk M, Haque S, Sterk P, Nizankowska Mogilnicka E, Papi A, Bel E, et al. Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study. Thorax. 2013;68:611-8 pubmed publisher

Zhong N, Lin J, Mehta P, Ngamjanyaporn P, Wu T, Yunus F. Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study. BMC Pulm Med. 2013;13:22 pubmed publisher

Wei C, Adappa N, Cohen N. Use of topical nasal therapies in the management of chronic rhinosinusitis. Laryngoscope. 2013;123:2347-59 pubmed publisher

. Budesonide (Uceris) for ulcerative colitis. Med Lett Drugs Ther. 2013;55:23-4 pubmed

Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, et al. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study. J Intern Med. 2013;273:584-94 pubmed publisher

Kramer S, Rottier B, Scholten R, Boluyt N. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev. 2013;:CD010352 pubmed publisher

Rachelefsky G, Farrar J. A control model to evaluate pharmacotherapy for allergic rhinitis in children. JAMA Pediatr. 2013;167:380-6 pubmed publisher

Lu Y, Sun Z, Zhang Y, Chen X, Zhong D. Simultaneous quantification of 22R and 22S epimers of budesonide in human plasma by ultra-high-performance liquid chromatography-tandem mass spectrometry: application in a stereoselective pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;921-922:27-34 pubmed publisher

Marquez Ruiz J, Kedziora K, Pigott M, Keogh B, Windle H, Gavin J, et al. A nitrophenyl-based prodrug type for colorectal targeting of prednisolone, budesonide and celecoxib. Bioorg Med Chem Lett. 2013;23:1693-8 pubmed publisher

Sann H, Erichsen J, Hessmann M, Pahl A, Hoffmeyer A. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life Sci. 2013;92:708-18 pubmed publisher

Yousef E, Hossain J, Mannan S, Skorpinski E, MCGEADY S. Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: a randomized controlled trial. Allergy Asthma Proc. 2012;33:508-13 pubmed publisher

Wang P, Wang X, Yang X, Liu Z, Wu M, Li G. Budesonide suppresses pulmonary antibacterial host defense by down-regulating cathelicidin-related antimicrobial peptide in allergic inflammation mice and in lung epithelial cells. BMC Immunol. 2013;14:7 pubmed publisher

Gupta A, Kshirsagar S, Bhalekar M, Saldanha T. Design and development of liposomes for colon targeted drug delivery. J Drug Target. 2013;21:146-60 pubmed publisher

Rodriguez Martinez C, Sossa Briceño M, Castro Rodriguez J. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma. J Asthma. 2013;50:410-8 pubmed publisher

Criscuoli V, Sinagra E, Cottone M. Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis. Gastroenterology. 2013;144:e23 pubmed publisher

Itazawa T, Adachi Y, Ito Y, Higuchi O, Mochizuki H, Shimojo N, et al. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol. Allergol Int. 2013;62:131-5 pubmed publisher

Wardhana -, Datau E. A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans. Acta Med Indones. 2012;44:317-23 pubmed

Gross V. Topical therapy. Dig Dis. 2012;30 Suppl 3:92-9 pubmed publisher

Gentile N, Abdalla A, Khanna S, Smyrk T, Tremaine W, Faubion W, et al. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol. 2013;108:256-9 pubmed publisher

Abenavoli L, Milic N, Beaugrand M. Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report. Ann Hepatol. 2013;12:152-5 pubmed

Zur E. Eosinophilic esophagitis: treatment with oral viscous budesonide. Int J Pharm Compd. 2012;16:288-93 pubmed

Scott L. Budesonide/formoterol Turbuhaler®: a review of its use in chronic obstructive pulmonary disease. Drugs. 2012;72:395-414 pubmed publisher

Lasserson T, Ferrara G, Casali L. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database Syst Rev. 2011;:CD004106 pubmed publisher

Efe C, Ozaslan E, Kav T, Purnak T, Shorbagi A, Ozkayar O, et al. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. Autoimmun Rev. 2012;11:330-4 pubmed publisher

Snider K, Potter T. Budesonide for the treatment of autoimmune hepatitis. Ann Pharmacother. 2011;45:1144-50 pubmed publisher

Silverman J, Otley A. Budesonide in the treatment of inflammatory bowel disease. Expert Rev Clin Immunol. 2011;7:419-28 pubmed publisher

Stewart M, Seow C, Storr M. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2011;9:881-90 pubmed publisher

Cope S, Capkun Niggli G, Gale R, Jardim J, Jansen J. Comparative efficacy of indacaterol 150 ?g and 300 ?g versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis. Int J Chron Obstruct Pulmon Dis. 2011;6:329-44 pubmed publisher

Halpin D, Gray J, Edwards S, Morais J, Singh D. Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. Int J Clin Pract. 2011;65:764-74 pubmed publisher

Braido F, Baiardini I, Compalati E, Bordo A, Canonica G. Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research. Curr Opin Allergy Clin Immunol. 2011;11:361-74 pubmed publisher

Tashkin D. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD. Expert Rev Respir Med. 2010;4:703-14 pubmed publisher

Sharafkhaneh A, Mattewal A, Abraham V, Dronavalli G, Hanania N. Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis. 2010;5:357-66 pubmed publisher

Sherlock M, Seow C, Steinhart A, Griffiths A. Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2010;:CD007698 pubmed publisher

Hodgson D, Mortimer K, Harrison T. Budesonide/formoterol in the treatment of asthma. Expert Rev Respir Med. 2010;4:557-66 pubmed publisher

Peces Barba Romero G, Villar Alvarez F. [Budesonide/formoterol in the treatment of COPD]. Arch Bronconeumol. 2010;46 Suppl 4:22-7 pubmed publisher

Tangri V, Chande N. Use of budesonide in the treatment of microscopic colitis. Saudi J Gastroenterol. 2010;16:236-8 pubmed publisher

Berger W, Noonan M. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. J Asthma. 2010;47:447-59 pubmed publisher

Korenblat P, Rosenwasser L. Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma. Allergy Asthma Proc. 2010;31:190-202 pubmed publisher

Wong S, Belvisi M, Birrell M. MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies. Respir Res. 2009;10:72 pubmed publisher

Meja K, Rajendrasozhan S, Adenuga D, Biswas S, Sundar I, Spooner G, et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol. 2008;39:312-23 pubmed publisher

Stellato C, Matsukura S, Fal A, White J, Beck L, Proud D, et al. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol. 1999;163:5624-32 pubmed

Szefler S. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid. J Allergy Clin Immunol. 1999;104:175-83 pubmed

Adcock I, Nasuhara Y, Stevens D, Barnes P. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol. 1999;127:1003-11 pubmed

Larsson S, Linden M. Effects of a corticosteroid, budesonide, on production of bioactive IL-12 by human monocytes. Cytokine. 1998;10:786-9 pubmed